527 related articles for article (PubMed ID: 12783988)
1. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
[TBL] [Abstract][Full Text] [Related]
2. Lamin A/C assembly defects in Emery-Dreifuss muscular dystrophy can be regulated by culture medium composition.
Holt I; Nguyen TM; Wehnert M; Morris GE
Neuromuscul Disord; 2006 Jun; 16(6):368-73. PubMed ID: 16697197
[TBL] [Abstract][Full Text] [Related]
3. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
Holt I; Clements L; Manilal S; Brown SC; Morris GE
Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760
[TBL] [Abstract][Full Text] [Related]
4. How does a g993t mutation in the emerin gene cause Emery-Dreifuss muscular dystrophy?
Holt I; Clements L; Manilal S; Morris GE
Biochem Biophys Res Commun; 2001 Oct; 287(5):1129-33. PubMed ID: 11587540
[TBL] [Abstract][Full Text] [Related]
5. Nuclear envelope proteins and chromatin arrangement: a pathogenic mechanism for laminopathies.
Maraldi NM; Lattanzi G; Capanni C; Columbaro M; Merlini L; Mattioli E; Sabatelli P; Squarzoni S; Manzoli FA
Eur J Histochem; 2006; 50(1):1-8. PubMed ID: 16584978
[TBL] [Abstract][Full Text] [Related]
6. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
[TBL] [Abstract][Full Text] [Related]
7. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization.
Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC
Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902
[TBL] [Abstract][Full Text] [Related]
8. Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells.
Bechert K; Lagos-Quintana M; Harborth J; Weber K; Osborn M
Exp Cell Res; 2003 May; 286(1):75-86. PubMed ID: 12729796
[TBL] [Abstract][Full Text] [Related]
9. Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes.
Holaska JM; Rais-Bahrami S; Wilson KL
Hum Mol Genet; 2006 Dec; 15(23):3459-72. PubMed ID: 17067998
[TBL] [Abstract][Full Text] [Related]
10. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy.
Motsch I; Kaluarachchi M; Emerson LJ; Brown CA; Brown SC; Dabauvalle MC; Ellis JA
Eur J Cell Biol; 2005 Sep; 84(9):765-81. PubMed ID: 16218190
[TBL] [Abstract][Full Text] [Related]
11. Direct interaction between emerin and lamin A.
Clements L; Manilal S; Love DR; Morris GE
Biochem Biophys Res Commun; 2000 Jan; 267(3):709-14. PubMed ID: 10673356
[TBL] [Abstract][Full Text] [Related]
12. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.
Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM
Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684
[TBL] [Abstract][Full Text] [Related]
13. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.
Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G
J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034
[TBL] [Abstract][Full Text] [Related]
14. TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy.
Liang WC; Mitsuhashi H; Keduka E; Nonaka I; Noguchi S; Nishino I; Hayashi YK
Ann Neurol; 2011 Jun; 69(6):1005-13. PubMed ID: 21391237
[TBL] [Abstract][Full Text] [Related]
15. Emerin interacts in vitro with the splicing-associated factor, YT521-B.
Wilkinson FL; Holaska JM; Zhang Z; Sharma A; Manilal S; Holt I; Stamm S; Wilson KL; Morris GE
Eur J Biochem; 2003 Jun; 270(11):2459-66. PubMed ID: 12755701
[TBL] [Abstract][Full Text] [Related]
16. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy.
Ostlund C; Bonne G; Schwartz K; Worman HJ
J Cell Sci; 2001 Dec; 114(Pt 24):4435-45. PubMed ID: 11792809
[TBL] [Abstract][Full Text] [Related]
17. Characterization of unfolding mechanism of human lamin A Ig fold by single-molecule force spectroscopy-implications in EDMD.
Bera M; Kotamarthi HC; Dutta S; Ray A; Ghosh S; Bhattacharyya D; Ainavarapu SR; Sengupta K
Biochemistry; 2014 Nov; 53(46):7247-58. PubMed ID: 25343322
[TBL] [Abstract][Full Text] [Related]
18. Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle.
Zhang Q; Ragnauth CD; Skepper JN; Worth NF; Warren DT; Roberts RG; Weissberg PL; Ellis JA; Shanahan CM
J Cell Sci; 2005 Feb; 118(Pt 4):673-87. PubMed ID: 15671068
[TBL] [Abstract][Full Text] [Related]
19. The cell cycle dependent mislocalisation of emerin may contribute to the Emery-Dreifuss muscular dystrophy phenotype.
Fairley EA; Riddell A; Ellis JA; Kendrick-Jones J
J Cell Sci; 2002 Jan; 115(Pt 2):341-54. PubMed ID: 11839786
[TBL] [Abstract][Full Text] [Related]
20. Nuclear envelope proteins and neuromuscular diseases.
Ostlund C; Worman HJ
Muscle Nerve; 2003 Apr; 27(4):393-406. PubMed ID: 12661041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
